BeOne Medicines Reports 42% Revenue Growth in Q2 2025 Driven by Brukinsa Sales
BeOne Medicines Ltd. (NASDAQ: ONC; HKG: 6160; SHA: 688235) announced its financial results and business...
Finanical Reports
Pfizer’s Q2 2025 Revenue Rises 10% Driven by Strong Biopharma Sales
US-based Pfizer Inc. (NYSE: PFE) reported Q2 2025 financial results, revealing a 10% year-on-year (YOY)...
Novo Nordisk Reports Strong H1 2025 Financial Results Driven by Semaglutide Sales
Danish biopharmaceutical giant Novo Nordisk A/S (NYSE: NVO) announced its financial results for the first...
AbbVie Reports Strong Q2 2025 Results With Immunology Portfolio Leading Growth
US-based multinational AbbVie Inc. (NYSE: ABBV) reported strong Q2 2025 results with global revenues increasing...
BMS Q2 Earnings Reflect Strategic Investments; Maintains Full-Year Revenue Growth Outlook
US major Bristol-Myers Squibb (BMS; NYSE: BMY) reported Q2 2025 financial results, revealing total revenues...
GSK Reports 6% Sales Growth in Q2 2025, Driven by Specialty Medicine and Vaccines
UK-based GlaxoSmithKline (GSK; NYSE: GSK) released its Q2 and H1 2025 financial results. Q2 sales...
MSD’s Q2 Earnings Hit by Gardasil Sales Decline, Keytruda Growth Slows
US-based Merck, Sharp & Dohme Inc. (MSD; NYSE: MRK) announced its Q2 2025 financial results,...
Wuxi Apptec Reports Strong Q2 2025 Results with 20.6% Revenue Growth
China-based Contract Research Organization (CRO) WuXi AppTec (SHA: 603259, HKG: 2359) announced strong growth in...
Roche AG Reports 7% Sales Growth in H1 2025, Driven by Pharmaceuticals Expansion
Swiss giant Roche AG (SWX: ROG, OTCMKTS: RHHBY) announced its H1 2025 financial results, reporting...
Boehringer Ingelheim Reports 6.3% Sales Growth in First Half of 2025
Boehringer Ingelheim announced today its financial results for the first half of 2025, reporting group...
Abbott Reports Q2 2025 Sales of USD 11.14 Billion, Led by Medical Devices Growth
Abbott (NYSE: ABT) reported global sales of USD 11.14 billion for the second quarter of...
Novartis Reports Double-Digit Growth in Q2 and 1H25, Driven by Key Brands
Swiss pharmaceutical giant Novartis (NYSE: NVS) reported double-digit growth in both revenue and net income...
Johnson & Johnson Reports 5.8% Sales Growth in 2025Q2, Increases Full-Year Guidance
US giant Johnson & Johnson (J&J, NYSE: JNJ) announced its second-quarter 2025 (2025Q2) results, reporting...
Burning Rock Reports Q1 2025 Revenue Growth and R&D Progress
China-based medtech firm Burning Rock Ltd (NASDAQ: BNR) released its Q1 2025 financial report, showing a...
Medtronic Reports Q4 and FY2025 Results with Revenue Growth Across Key Segments
US-Irish firm Medtronic (NYSE: MDT) released financial results for its fourth quarter (Q4) and fiscal...
Alibaba Health Reports Strong 2025 Financial Results with Revenue Hike
China-based Alibaba Health Information Technology Ltd (HKG: 0241) released its 2025 financial report for the...
Merck KGaA Reports Q1 2025 Financials with 2.5% Organic Sales Growth
Merck KGaA (ETR: MRK) released its Q1 2025 financial results, reporting a 2.5% year-on-year (YOY)...
Bayer Reports Flat Q1 Revenue amid Crop Science Decline
German pharmaceutical and chemical giant Bayer (ETR: BAYN) released its Q1 2025 financial report, recording...
InnoCare Pharma Reports 129.92% Revenue Surge in Q1 2025, Turns Profitable
Beijing-based biotech InnoCare Pharma (HKG: 9969, SHA: 688428) released its Q1 2025 financial report, recording...
JD Healthcare Reports 25.5% Revenue Growth in Q1 2025
JD Healthcare (HKG: 6618), a subsidiary of China’s e-commerce giant JD.com (NASDAQ: JD), released its...